en

PRODUCT DETAIL

Tyverb 250 mg filmom obalené tablety

Code 51522
MA number EU/1/07/440/001
Product Form: tbl flm 70x250 mg (blis.PA/Al/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EH01 Lapatinib
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 10.06.2008
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Tyverb 10 12 2012.pdf  
Safety feature Yes
Data update: 12.10.2022
eu-flag.png sk-flag.png